Menu Search
Equities

Envoy Medical Inc

COCH:NAQ

Envoy Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.23
  • Today's Change0.039 / 1.22%
  • Shares traded4.56k
  • 1 Year change-69.07%
  • Beta2.3205
Data delayed at least 15 minutes, as of Sep 20 2024 20:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Envoy Medical Inc had net income fall 87.83% from a loss of 15.92m to a larger loss of 29.91m despite a 33.33% increase in revenues from 237.00k to 316.00k. An increase in the selling, general and administrative costs as a percentage of sales from 1,464.14% to 2,829.75% was a component in the falling net income despite rising revenues.
Gross margin-171.85%
Net profit margin-4,481.79%
Operating margin-6,582.12%
Return on assets-290.14%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, Envoy Medical Inc increased its cash reserves by 2,204.92%, or 4.04m. Cash Flow from Financing totalled 21.85m or 6,912.97% of revenues. In addition the company used 17.65m for operations while cash used for investing totalled 153.00k.
Cash flow per share-0.9185
Price/Cash flow per share--
Book value per share-0.632
Tangible book value per share-0.632
More ▼

Balance sheet in USDView more

Envoy Medical Inc uses little or no debt in its capital structure.
Current ratio0.62
Quick ratio0.4237
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.